These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25162670)

  • 1. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.
    Agrati C; Castilletti C; Cimini E; Lapa D; Quartu S; Caglioti C; Lanini S; Cattoli G; Martini F; Ippolito G; Capobianchi MR
    PLoS One; 2014; 9(8):e105651. PubMed ID: 25162670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.
    Agrati C; Gioia C; Castilletti C; Lapa D; Berno G; Puro V; Carletti F; Cimini E; Nisii C; Castellino F; Martini F; Capobianchi MR
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1606-16. PubMed ID: 22439734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).
    Skowronski DM; Janjua NZ; De Serres G; Purych D; Gilca V; Scheifele DW; Dionne M; Sabaiduc S; Gardy JL; Li G; Bastien N; Petric M; Boivin G; Li Y
    J Infect Dis; 2012 Dec; 206(12):1852-61. PubMed ID: 22872731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
    Munoz FM; Anderson EJ; Bernstein DI; Harrison CJ; Pahud B; Anderson E; Creech CB; Berry AA; Kotloff KL; Walter EB; Atmar RL; Bellamy AR; Chang S; Keitel WA
    Vaccine; 2019 Aug; 37(36):5161-5170. PubMed ID: 31375440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.
    Radin JM; Hawksworth AW; Ortiguerra RG; Brice GT
    PLoS One; 2015; 10(3):e0121037. PubMed ID: 25816244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower seroreactivity to European than to North American H3N2 swine influenza viruses in humans, Luxembourg, 2010.
    Qiu Y; Muller CP; Van Reeth K
    Euro Surveill; 2015 Apr; 20(13):25-33. PubMed ID: 25860393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.
    Luo Z; Ma L; Zhang L; Martin L; Wan Z; Warth S; Kilby A; Gao Y; Bhargava P; Li Z; Wu H; Meissner EG; Li Z; Kilby JM; Liao G; Jiang W
    Vaccine; 2016 Apr; 34(16):1945-55. PubMed ID: 26721328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
    Iorio AM; Bistoni O; Galdiero M; Lepri E; Camilloni B; Russano AM; Neri M; Basileo M; Spinozzi F
    Vaccine; 2012 Feb; 30(9):1617-23. PubMed ID: 22245606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
    van der Velden MV; Geisberger A; Dvorak T; Portsmouth D; Fritz R; Crowe BA; Herr W; Distler E; Wagner EM; Zeitlinger M; Sauermann R; Stephan C; Ehrlich HJ; Barrett PN; Aichinger G
    Clin Vaccine Immunol; 2014 Jun; 21(6):867-76. PubMed ID: 24739978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against influenza in patients with systemic sclerosis.
    Litinsky I; Balbir A; Zisman D; Mandelboim M; Mendelson E; Feld J; Braun Y; Anouk M; Kaufman I; Paran D; Caspi D; Elkayam O
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S7-11. PubMed ID: 22409886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation.
    Wheatley AK; Kristensen AB; Lay WN; Kent SJ
    Sci Rep; 2016 May; 6():26478. PubMed ID: 27220898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
    Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
    Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the trivalent influenza vaccination in Thai patients with hemodialysis or kidney transplant compared with healthy volunteers.
    Krairittichai U; Chittaganpitch M
    J Med Assoc Thai; 2013 Mar; 96 Suppl 3():S1-7. PubMed ID: 23682516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
    Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
    Front Immunol; 2018; 9():2465. PubMed ID: 30405641
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines.
    Jang H; Ross TM
    PLoS One; 2021; 16(10):e0258453. PubMed ID: 34679115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune responses after influenza vaccination in patients with postcancer fatigue.
    Prinsen H; van Laarhoven HW; Pots JM; Duiveman-de Boer T; Mulder SF; van Herpen CM; Jacobs JF; Leer JW; Bleijenberg G; Stelma FF; Torensma R; de Vries IJ
    Hum Vaccin Immunother; 2015; 11(7):1634-40. PubMed ID: 25996472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Likelihood of prior exposure to circulating influenza viruses resulting in cross-protection by CD8+ T cells against emergent H3N2v swine viruses infecting humans.
    Komadina N; Sullivan SG; Leder K; McVernon J
    J Med Virol; 2022 Feb; 94(2):567-574. PubMed ID: 34449904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions.
    Skowronski DM; Moser FS; Janjua NZ; Davoudi B; English KM; Purych D; Petric M; Pourbohloul B
    PLoS One; 2013; 8(1):e54015. PubMed ID: 23326561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.